37 related articles for article (PubMed ID: 19101472)
1. Engineering stable and non-immunogenic immunoenzymes for cancer therapy via in situ generated prodrugs.
Tseng YH; Lin HP; Lin SY; Chen BM; Vo TNN; Yang SH; Lin YC; Prijovic Z; Czosseck A; Leu YL; Roffler SR
J Control Release; 2024 May; 369():179-198. PubMed ID: 38368947
[TBL] [Abstract][Full Text] [Related]
2. Rapid directed molecular evolution of fluorescent proteins in mammalian cells.
Babakhanova S; Jung EE; Namikawa K; Zhang H; Wang Y; Subach OM; Korzhenevskiy DA; Rakitina TV; Xiao X; Wang W; Shi J; Drobizhev M; Park D; Eisenhard L; Tang H; Köster RW; Subach FV; Boyden ES; Piatkevich KD
Protein Sci; 2022 Mar; 31(3):728-751. PubMed ID: 34913537
[TBL] [Abstract][Full Text] [Related]
3. X-Ray Crystallography in Structure-Function Characterization of Therapeutic Enzymes.
Papageorgiou AC
Adv Exp Med Biol; 2019; 1148():81-103. PubMed ID: 31482495
[TBL] [Abstract][Full Text] [Related]
4. Engineering Novel and Improved Biocatalysts by Cell Surface Display.
Smith MR; Khera E; Wen F
Ind Eng Chem Res; 2015 Apr; 54(16):4021-4032. PubMed ID: 29056821
[TBL] [Abstract][Full Text] [Related]
5. Annexin-directed β-glucuronidase for the targeted treatment of solid tumors.
Guillen KP; Ruben EA; Virani N; Harrison RG
Protein Eng Des Sel; 2017 Feb; 30(2):85-94. PubMed ID: 27986920
[TBL] [Abstract][Full Text] [Related]
6. HIV Vaccine Design to Target Germline Precursors of Glycan-Dependent Broadly Neutralizing Antibodies.
Steichen JM; Kulp DW; Tokatlian T; Escolano A; Dosenovic P; Stanfield RL; McCoy LE; Ozorowski G; Hu X; Kalyuzhniy O; Briney B; Schiffner T; Garces F; Freund NT; Gitlin AD; Menis S; Georgeson E; Kubitz M; Adachi Y; Jones M; Mutafyan AA; Yun DS; Mayer CT; Ward AB; Burton DR; Wilson IA; Irvine DJ; Nussenzweig MC; Schief WR
Immunity; 2016 Sep; 45(3):483-496. PubMed ID: 27617678
[TBL] [Abstract][Full Text] [Related]
7. Effect of Cellular Location of Human Carboxylesterase 2 on CPT-11 Hydrolysis and Anticancer Activity.
Hsieh YT; Lin HP; Chen BM; Huang PT; Roffler SR
PLoS One; 2015; 10(10):e0141088. PubMed ID: 26509550
[TBL] [Abstract][Full Text] [Related]
8. High Throughput Screening and Selection Methods for Directed Enzyme Evolution.
Xiao H; Bao Z; Zhao H
Ind Eng Chem Res; 2015 Apr; 54(16):4011-4020. PubMed ID: 26074668
[TBL] [Abstract][Full Text] [Related]
9. Engineering an enhanced, thermostable, monomeric bacterial luciferase gene as a reporter in plant protoplasts.
Cui B; Zhang L; Song Y; Wei J; Li C; Wang T; Wang Y; Zhao T; Shen X
PLoS One; 2014; 9(10):e107885. PubMed ID: 25271765
[TBL] [Abstract][Full Text] [Related]
10. Directed evolution: selection of the host organism.
Pourmir A; Johannes TW
Comput Struct Biotechnol J; 2012; 2():e201209012. PubMed ID: 24688653
[TBL] [Abstract][Full Text] [Related]
11. The B7-1 cytoplasmic tail enhances intracellular transport and mammalian cell surface display of chimeric proteins in the absence of a linear ER export motif.
Lin YC; Chen BM; Lu WC; Su CI; Prijovich ZM; Chung WC; Wu PY; Chen KC; Lee IC; Juan TY; Roffler SR
PLoS One; 2013; 8(9):e75084. PubMed ID: 24073236
[TBL] [Abstract][Full Text] [Related]
12. Bacterial glucuronidase as general marker for oncolytic virotherapy or other biological therapies.
Hess M; Stritzker J; Härtl B; Sturm JB; Gentschev I; Szalay AA
J Transl Med; 2011 Oct; 9():172. PubMed ID: 21989091
[TBL] [Abstract][Full Text] [Related]
13. Directed evolution of a lysosomal enzyme with enhanced activity at neutral pH by mammalian cell-surface display.
Chen KC; Wu CH; Chang CY; Lu WC; Tseng Q; Prijovich ZM; Schechinger W; Liaw YC; Leu YL; Roffler SR
Chem Biol; 2008 Dec; 15(12):1277-86. PubMed ID: 19101472
[TBL] [Abstract][Full Text] [Related]
14. Cell surface display of a lysosomal enzyme for extracellular gene-directed enzyme prodrug therapy.
Heine D; Müller R; Brüsselbach S
Gene Ther; 2001 Jul; 8(13):1005-10. PubMed ID: 11438835
[TBL] [Abstract][Full Text] [Related]
15. Membrane-localized activation of glucuronide prodrugs by beta-glucuronidase enzymes.
Chen KC; Cheng TL; Leu YL; Prijovich ZM; Chuang CH; Chen BM; Roffler SR
Cancer Gene Ther; 2007 Feb; 14(2):187-200. PubMed ID: 16977328
[TBL] [Abstract][Full Text] [Related]
16. Engineering a thermostable human prolyl endopeptidase for antibody-directed enzyme prodrug therapy.
Heinis C; Alessi P; Neri D
Biochemistry; 2004 May; 43(20):6293-303. PubMed ID: 15147213
[TBL] [Abstract][Full Text] [Related]
17. Ultra-high-throughput screening based on cell-surface display and fluorescence-activated cell sorting for the identification of novel biocatalysts.
Becker S; Schmoldt HU; Adams TM; Wilhelm S; Kolmar H
Curr Opin Biotechnol; 2004 Aug; 15(4):323-9. PubMed ID: 15296929
[TBL] [Abstract][Full Text] [Related]
18. Beta-glucuronidase-mediated drug release.
de Graaf M; Boven E; Scheeren HW; Haisma HJ; Pinedo HM
Curr Pharm Des; 2002; 8(15):1391-403. PubMed ID: 12052215
[TBL] [Abstract][Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
